REGENERATIVE FIBROBLASTENZELLEN
European patent · EP3908297 · In force
Register entry
- Publication number
- EP3908297
- Application number
- EP20738380
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jan 13, 2020
- Published
- Nov 17, 2021
- Granted
- Oct 22, 2025
- Protection ends at the latest
- Jan 12, 2040
- Next annual fee due
- Jan 31, 2027
- IPC classes
- A61K 35/33 (2015.01)C12N 5/00 (2006.01)A61K 35/12 (2015.01)A61K 45/06 (2006.01)A61P 37/02 (2006.01)C12N 5/077 (2010.01)
- Priority
- US 201962791207 P 11.01.2019
- PCT application
- PCT/US2020/013315 13.01.2020
- PCT publication
- WO2020/146874 16.07.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 2, 2026
Change
Published in Swissreg on 02.09.2026
- Feb 16, 2026
Next annual fee due on
- Next annual fee due on
- 31.01.2026 → 31.01.2027
Published in Swissreg on 16.02.2026
- Jan 9, 2026
Agent entered
- Representative
- Isler & Pedrazzini AG, Postfach, 8027 Zürich
Published in Swissreg on 09.01.2026
- Oct 22, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 22.10.2025
Parties
Inventor
O'HEERON, Pete
Houston, Texas 77059, US
ICHIM, Thomas
Houston, Texas 77058, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.